Your browser doesn't support javascript.
loading
The MRVI1-AS1/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway.
Zhu, Yuxing; He, Dong; Bo, Hao; Liu, Zexian; Xiao, Mengqing; Xiang, Liang; Zhou, Jianda; Liu, Yan; Liu, Xiaoming; Gong, Lian; Ma, Yanni; Zhou, Yanhong; Zhou, Ming; Xiong, Wei; Yang, Fei; Xing, Xiaowei; Li, Ruhong; Li, Wei; Cao, Ke.
Affiliation
  • Zhu Y; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • He D; Department of Respiration, The Second People's Hospital of Hunan Province of Hunan University of Chinese Medicine, Changsha, 410000, People's Republic of China.
  • Bo H; Institute of Reproductive and Stem Cell Engineering, Central South University, 410083, Changsha, Hunan, People's Republic of China.
  • Liu Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, 510060, Guangzhou, People's Republic of China.
  • Xiao M; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • Xiang L; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • Zhou J; Department of Plastic Surgery, Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, People's Republic of China.
  • Liu Y; Department of Plastic Surgery, Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, People's Republic of China.
  • Liu X; Department of Gastroenterology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • Gong L; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • Ma Y; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China.
  • Zhou Y; Cancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, 410078, Changsha, People's Republic of China.
  • Zhou M; Cancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, 410078, Changsha, People's Republic of China.
  • Xiong W; Cancer Research Institute and Key Laboratory of Carcinogenesis of Ministry of Health, Central South University, 410078, Changsha, People's Republic of China.
  • Yang F; School of Public Health, Central South University, 410078, Changsha, Hunan, People's Republic of China.
  • Xing X; Center for Medical Experiments, Third Xiangya Hospital, Central South University, 410013, Changsha, People's Republic of China.
  • Li R; Yan'an Affiliated Hospital of Kunming Medical University, 650051, Kunming, People's Republic of China.
  • Li W; Department of Otolaryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University, 410013, Changsha, Hunan, People's Republic of China.
  • Cao K; Department of Oncology, Third Xiangya Hospital of Central South University, 410013, Changsha, People's Republic of China. csucaoke@163.com.
Oncogene ; 38(32): 6065-6081, 2019 08.
Article in En | MEDLINE | ID: mdl-31273338
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Phosphoproteins / Nasopharyngeal Neoplasms / RNA, Antisense / Paclitaxel / Activating Transcription Factor 3 / Nasopharyngeal Carcinoma / Membrane Proteins Language: En Journal: Oncogene Year: 2019 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Plantas_medicinales Main subject: Phosphoproteins / Nasopharyngeal Neoplasms / RNA, Antisense / Paclitaxel / Activating Transcription Factor 3 / Nasopharyngeal Carcinoma / Membrane Proteins Language: En Journal: Oncogene Year: 2019 Type: Article